Apyx Medical Corp (APYX)
NASDAQHealth CareMedical - SpecialtiesSnapshot 2026-11-04
$3.06+18.15%
Close 2026-11-05 · 1-day change
NASDAQHealth CareMedical - SpecialtiesSnapshot 2026-11-04
QuarterlyIQ Insights · APYX
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance sits well below its industry cohort — worth keeping an eye on, though it has not freshly broken.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | -56.6% |
| Our one-year growth estimate | diamond |
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
Usually moved in the same direction.
Price observations: 365 days
Most sensitive to the broad stock market.
Based on historical daily prices through 2026-11-04.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| 11.1% |
Growth built into the price is above our model estimate.
The price assumes 67.8 percentage points less one-year growth.
The one-year revenue growth assumption on Valuation.
Model as of 2026-11-04 · Compared with 1 industry peers
APYX — earnings miss
Dated 2026-08-06
Results of Operations and Financial Condition On August 6, 2026, Apyx Medical Corporation (the "Company") issued a press release reporting on its results of operations for the second quarter ended June 30, 2026. A copy of that press release is attached hereto as Exhibit 99.1 and incorporated by reference herein. This information is intended to be furnished under
Why it matters: This segment drove most recent sales growth. OEM sales fell 12% in Q2, so the main growth engine matters.
Watch forQ3 Surgical Aesthetics sales rise at least 20% year over year from the Q3 2025 level.
Also watch forQ3 Surgical Aesthetics sales rise less than 10% year over year or fall from a year earlier.
Why it matters: The new handpiece could help AYON sales grow. The launch began with a small group of surgeons in June.
Supportive ifApyx reports that more surgeons use the AYON power liposuction handpiece. Or, shipments rise after its limited launch.
Worry ifApyx reports no wider rollout, weak handpiece orders, or a pause in shipments.
Why it matters: The company needs strong second-half sales to reach its full-year revenue range. Q3 results are due November 5.
Watch forOn November 5, Apyx reports Q3 revenue and keeps its 2026 revenue range at $59M–$60M, with sales tracking toward that range.
Also watch forApyx cuts its 2026 revenue range below $59M or reports Q3 sales that make the range hard to reach.
Why it matters: A smaller loss would show progress toward better results. Apyx lost $0.7M on this measure in Q2.
Supportive ifQ3 adjusted EBITDA loss is less than $0.7M, compared with the $0.7M loss in Q2 2026.
Worry ifQ3 adjusted EBITDA loss is $0.7M or more, or the company reports a wider loss than in Q2.
We watch for confirming and disproving signals on each item. Resolutions are found automatically where possible and checked by hand for unclear cases. Last 90 days shown.
A larger daily loss that occurred about once in every 20 trading days.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$193 on $10,000 · ±1.9% | How much price usually moves either way. |
| Bad day | $649 loss on $10,000 · 6.5% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $5,144 loss on $10,000 · 51.4% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.